2010 Q4 Form 10-K Financial Statement

#000119312512077126 Filed on February 24, 2012

View on sec.gov

Income Statement

Concept 2010 Q4 2010 Q3 2010 Q2
Revenue $483.6M $391.1M $367.7M
YoY Change 12.76% 7.78% 10.4%
Cost Of Revenue $189.3M $155.1M $145.9M
YoY Change 11.24% 7.62% 14.5%
Gross Profit $294.3M $235.9M $221.8M
YoY Change 13.76% 7.88% 7.86%
Gross Profit Margin 60.86% 60.33% 60.31%
Selling, General & Admin $120.5M $106.9M $106.7M
YoY Change 9.58% -2.41% 7.6%
% of Gross Profit 40.95% 45.33% 48.11%
Research & Development $22.87M $20.81M $20.08M
YoY Change 15.55% 5.5% 9.51%
% of Gross Profit 7.77% 8.82% 9.05%
Depreciation & Amortization $15.20M $15.40M $8.441M
YoY Change 10.95% 6.21% -41.38%
% of Gross Profit 5.16% 6.53% 3.81%
Operating Expenses $143.4M $127.7M $126.8M
YoY Change 10.49% -1.21% 7.9%
Operating Profit $103.8M $105.6M $92.36M
YoY Change -17.81% 21.79% 8.03%
Interest Expense $3.810M $3.621M $2.614M
YoY Change 62.61% 36.69% -16.49%
% of Operating Profit 3.67% 3.43% 2.83%
Other Income/Expense, Net
YoY Change
Pretax Income $144.9M $102.4M $90.07M
YoY Change 16.16% 20.99% 8.17%
Income Tax $18.26M $17.49M $14.55M
% Of Pretax Income 12.6% 17.08% 16.16%
Net Earnings $94.70M $84.90M $75.50M
YoY Change 24.77% 21.46% 3.0%
Net Earnings / Revenue 19.58% 21.71% 20.53%
Basic Earnings Per Share
Diluted Earnings Per Share $1.015M $900.3K $793.1K
COMMON SHARES
Basic Shares Outstanding 91.71M shares 92.61M shares 93.63M shares
Diluted Shares Outstanding 93.29M shares 94.28M shares 95.22M shares

Balance Sheet

Concept 2010 Q4 2010 Q3 2010 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $837.1M $754.5M $692.2M
YoY Change 44.8% 49.2% 60.49%
Cash & Equivalents $308.5M $310.9M $297.0M
Short-Term Investments $574.3M $443.6M $395.2M
Other Short-Term Assets $77.69M $51.43M $53.90M
YoY Change 57.88% -16.1% -12.21%
Inventory $204.3M $191.8M $189.2M
Prepaid Expenses
Receivables $358.2M $314.2M $314.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.587B $1.312B $1.249B
YoY Change 35.34% 23.96% 29.72%
LONG-TERM ASSETS
Property, Plant & Equipment $215.1M $210.6M $209.0M
YoY Change 1.96% 3.61% 13.71%
Goodwill $291.7M $289.9M
YoY Change -0.48%
Intangibles $181.3M $172.2M
YoY Change -0.47%
Long-Term Investments
YoY Change
Other Assets $53.00M $51.76M $51.80M
YoY Change 7.31% -27.41% -21.87%
Total Long-Term Assets $741.0M $724.5M $732.0M
YoY Change 0.74% -2.65% 2.88%
TOTAL ASSETS
Total Short-Term Assets $1.587B $1.312B $1.249B
Total Long-Term Assets $741.0M $724.5M $732.0M
Total Assets $2.328B $2.036B $1.981B
YoY Change 22.0% 12.97% 18.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.41M $59.32M $57.80M
YoY Change 29.92% 15.63% 21.43%
Accrued Expenses $49.20M $41.60M $42.80M
YoY Change 9.09% 4.79% 6.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $92.20M $56.90M $12.40M
YoY Change -36.28% -56.5% -85.93%
Total Short-Term Liabilities $385.9M $362.6M $305.2M
YoY Change -2.21% -9.38% -11.15%
LONG-TERM LIABILITIES
Long-Term Debt $700.0M $700.0M $700.0M
YoY Change 40.0% 40.0% 40.0%
Other Long-Term Liabilities $22.64M $19.65M $90.50M
YoY Change -0.58% -78.87% 2.61%
Total Long-Term Liabilities $873.0M $860.9M $790.5M
YoY Change 31.4% 45.17% 34.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $385.9M $362.6M $305.2M
Total Long-Term Liabilities $873.0M $860.9M $790.5M
Total Liabilities $1.259B $1.223B $1.168B
YoY Change 18.88% 14.14% 15.8%
SHAREHOLDERS EQUITY
Retained Earnings $2.618B $2.397B
YoY Change 17.07%
Common Stock $971.6M $844.9M
YoY Change 19.97%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.509B $2.393B
YoY Change 13.39%
Treasury Stock Shares 59.21M shares 57.53M shares
Shareholders Equity $1.069B $813.0M $813.0M
YoY Change
Total Liabilities & Shareholders Equity $2.328B $2.036B $1.981B
YoY Change 22.0% 12.97% 18.32%

Cashflow Statement

Concept 2010 Q4 2010 Q3 2010 Q2
OPERATING ACTIVITIES
Net Income $94.70M $84.90M $75.50M
YoY Change 24.77% 21.46% 3.0%
Depreciation, Depletion And Amortization $15.20M $15.40M $8.441M
YoY Change 10.95% 6.21% -41.38%
Cash From Operating Activities $109.0M $111.6M $103.2M
YoY Change -12.52% 19.87% 27.83%
INVESTING ACTIVITIES
Capital Expenditures -$26.10M -$11.00M -$10.20M
YoY Change 15.49% -69.1% -54.05%
Acquisitions
YoY Change
Other Investing Activities -$130.8M -$48.40M -$106.0M
YoY Change 222.96% -53.51% 33.84%
Cash From Investing Activities -$156.7M -$59.50M -$116.2M
YoY Change 148.34% -57.41% 14.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $105.0M
YoY Change
Debt Paid & Issued, Net $132.7M
YoY Change
Cash From Financing Activities -18.70M -21.70M -$18.48M
YoY Change -45.0% -367.9% 31.99%
NET CHANGE
Cash From Operating Activities 109.0M 111.6M $103.2M
Cash From Investing Activities -156.7M -59.50M -$116.2M
Cash From Financing Activities -18.70M -21.70M -$18.48M
Net Change In Cash -66.40M 30.40M -$31.51M
YoY Change -341.45% -178.96% -9.19%
FREE CASH FLOW
Cash From Operating Activities $109.0M $111.6M $103.2M
Capital Expenditures -$26.10M -$11.00M -$10.20M
Free Cash Flow $135.1M $122.6M $113.4M
YoY Change -8.22% -4.74% 10.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011 dei Entity Registrant Name
EntityRegistrantName
WATERS CORP /DE/
CY2011 dei Entity Central Index Key
EntityCentralIndexKey
0001000697
CY2011 dei Document Type
DocumentType
10-K
CY2011 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2011 dei Amendment Flag
AmendmentFlag
false
CY2011 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
CY2011 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2011 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2011 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2011 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2011 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2011Q3 dei Entity Public Float
EntityPublicFloat
8920306459 USD
CY2011 dei Document Period End Date
DocumentPeriodEndDate
2011-12-31
CY2012Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
89060460 shares
CY2011 wat Percent Of Net Sales To Pharmaceutical Industry
PercentOfNetSalesToPharmaceuticalIndustry
0.52 pure
CY2010 wat Percent Of Net Sales To Pharmaceutical Industry
PercentOfNetSalesToPharmaceuticalIndustry
0.52 pure
CY2009 wat Percent Of Net Sales To Pharmaceutical Industry
PercentOfNetSalesToPharmaceuticalIndustry
0.51 pure
CY2011 wat Maximum Percentage Of Net Sales To Individual Customer
MaximumPercentageOfNetSalesToIndividualCustomer
0.03 pure
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
383990000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
367085000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
212864000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
80804000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1942104000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
237095000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
191992000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
297071000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54972000 USD
CY2011Q4 us-gaap Assets
Assets
2723234000 USD
CY2011Q4 us-gaap Debt Current
DebtCurrent
290832000 USD
CY2010Q4 us-gaap Debt Current
DebtCurrent
66055000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
55317000 USD
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
64406000 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49949000 USD
CY2010Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
52831000 USD
CY2011Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
109922000 USD
CY2010Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
106445000 USD
CY2011Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9449000 USD
CY2010Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
11909000 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
73136000 USD
CY2010Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
72932000 USD
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13258000 USD
CY2010Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11272000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
601863000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
385850000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
700000000 USD
CY2010Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
700000000 USD
CY2011Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
92970000 USD
CY2010Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
72624000 USD
CY2011Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
72613000 USD
CY2010Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
77764000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29210000 USD
CY2010Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22635000 USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
894793000 USD
CY2010Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
873023000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
1496656000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
1258873000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
1528000 USD
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
1511000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1089959000 USD
CY2010Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
970068000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3051447000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2618479000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2880301000 USD
CY2010Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2509466000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36055000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11795000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1226578000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
1068797000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2723234000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2327670000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
308498000 USD
CY2010Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
358237000 USD
CY2010Q4 us-gaap Inventory Net
InventoryNet
204300000 USD
CY2010Q4 us-gaap Other Assets Current
OtherAssetsCurrent
77685000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
1586641000 USD
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
215060000 USD
CY2010Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
181316000 USD
CY2010Q4 us-gaap Goodwill
Goodwill
291657000 USD
CY2010Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52996000 USD
CY2010Q4 us-gaap Assets
Assets
2327670000 USD
CY2011Q4 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
8584000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152757000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88996000 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
63761000 shares
CY2011 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
370835000 USD
CY2010Q4 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
6196000 USD
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2010 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
381763000 USD
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151054000 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91848000 shares
CY2010Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
59206000 shares
CY2011Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1281000000 USD
CY2010Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
946000000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1322136000 USD
CY2011 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
529048000 USD
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
1851184000 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
506073000 USD
CY2011 us-gaap Cost Of Services
CostOfServices
224420000 USD
CY2011 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
730493000 USD
CY2011 us-gaap Gross Profit
GrossProfit
1120691000 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
490011000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
92347000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
528600000 USD
CY2011 us-gaap Interest Expense
InterestExpense
21971000 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
2623000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
509252000 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76284000 USD
CY2011 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
432968000 USD
CY2011 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.77
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90833000 shares
CY2011 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.69
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92325000 shares
CY2010 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94057000 shares
CY2010 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.06
CY2010 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92385000 shares
CY2010 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.13
CY2010 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56100000 USD
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
437863000 USD
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
1855000 USD
CY2010 us-gaap Interest Expense
InterestExpense
13924000 USD
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
449932000 USD
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84274000 USD
CY2010 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
445456000 USD
CY2010 us-gaap Gross Profit
GrossProfit
990068000 USD
CY2010 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
653303000 USD
CY2010 us-gaap Cost Of Services
CostOfServices
199524000 USD
CY2010 us-gaap Cost Of Goods Sold
CostOfGoodsSold
453779000 USD
CY2010 us-gaap Sales Revenue Net
SalesRevenueNet
1643371000 USD
CY2010 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
476744000 USD
CY2010 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1166627000 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18838000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4309000 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12071000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11845000 USD
CY2011 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
11211000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
497374000 USD
CY2011 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
85436000 USD
CY2011 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1749161000 USD
CY2010 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
10406000 USD
CY2011 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
9733000 USD
CY2009 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1051978000 USD
CY2009 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
446722000 USD
CY2009 us-gaap Sales Revenue Net
SalesRevenueNet
1498700000 USD
CY2009 us-gaap Cost Of Goods Sold
CostOfGoodsSold
406681000 USD
CY2009 us-gaap Cost Of Services
CostOfServices
188201000 USD
CY2009 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
594882000 USD
CY2009 us-gaap Gross Profit
GrossProfit
903818000 USD
CY2009 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
421403000 USD
CY2009 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77154000 USD
CY2009 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
10659000 USD
CY2009 us-gaap Operating Income Loss
OperatingIncomeLoss
394602000 USD
CY2009 us-gaap Interest Expense
InterestExpense
10986000 USD
CY2009 us-gaap Investment Income Interest
InvestmentIncomeInterest
3036000 USD
CY2009 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
386652000 USD
CY2009 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63339000 USD
CY2009 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
323313000 USD
CY2009 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.37
CY2009 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95797000 shares
CY2009 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.34
CY2009 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96862000 shares
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.150 pure
CY2010 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.128 pure
CY2009 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.164 pure
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3265000 USD
CY2011 us-gaap Inventory Write Down
InventoryWriteDown
10131000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
27579000 USD
CY2011 us-gaap Depreciation
Depreciation
36531000 USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29856000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12528000 USD
CY2011 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1489721000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-355976000 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
598528000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
373751000 USD
CY2011 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4523000 USD
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
60153000 USD
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
370835000 USD
CY2011 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
32239000 USD
CY2011 us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
2233000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60422000 USD
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5484000 USD
CY2010 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
315641000 USD
CY2010 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18702000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
75492000 USD
CY2010 us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
8138000 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60252000 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32613000 USD
CY2010 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
43286000 USD
CY2010 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
37036000 USD
CY2010 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2402000 USD
CY2010 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2472000 USD
CY2010 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2926000 USD
CY2010 us-gaap Inventory Write Down
InventoryWriteDown
10897000 USD
CY2009 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
229244000 USD
CY2010 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
181358000 USD
CY2010 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
100584000 USD
CY2010 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
296292000 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-411515000 USD
CY2010 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1234671000 USD
CY2010 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
62740000 USD
CY2010 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2010 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
52017000 USD
CY2010 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3895000 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
457856000 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
24852000 USD
CY2010 us-gaap Depreciation
Depreciation
34421000 USD
CY2010 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28137000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
341111000 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
2630000 USD
CY2010 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
9433000 USD
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11100000 USD
CY2010 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
885896000 USD
CY2010 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1498000 USD
CY2010 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
10809000 USD
CY2009 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3124000 USD
CY2009 us-gaap Inventory Write Down
InventoryWriteDown
9952000 USD
CY2009 us-gaap Share Based Compensation
ShareBasedCompensation
28255000 USD
CY2009 us-gaap Depreciation
Depreciation
31805000 USD
CY2009 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25467000 USD
CY2009 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16905000 USD
CY2009 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6823000 USD
CY2009 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5925000 USD
CY2009 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
689000 USD
CY2009 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10830000 USD
CY2009 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
2613000 USD
CY2009 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13220000 USD
CY2009 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
418263000 USD
CY2009 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
93796000 USD
CY2009 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
36086000 USD
CY2009 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
518390000 USD
CY2009 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-419028000 USD
CY2009 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
184309000 USD
CY2009 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
92556000 USD
CY2009 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2009 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
19099000 USD
CY2009 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
211377000 USD
CY2009 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5083000 USD
CY2010 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3458000 USD
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4150000 USD
CY2009 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15855000 USD
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
97126000 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56003000 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
5083000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
10809000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
32239000 USD
CY2009 wat Adjustments To Additional Paid In Capital Increase In Valuation Allowance
AdjustmentsToAdditionalPaidInCapitalIncreaseInValuationAllowance
705000 USD
CY2010 wat Adjustments To Additional Paid In Capital Increase In Valuation Allowance
AdjustmentsToAdditionalPaidInCapitalIncreaseInValuationAllowance
-25873000 USD
CY2011 wat Adjustments To Additional Paid In Capital Increase In Valuation Allowance
AdjustmentsToAdditionalPaidInCapitalIncreaseInValuationAllowance
-176000 USD
CY2009 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28376000 USD
CY2011 us-gaap Nature Of Operations
NatureOfOperations
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (&#8220;Waters</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221; or the &#8220;Company&#8221;) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an ana</font><font style="font-family:Times New Roman;font-size:10pt;">lytical instrument manufacturer that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (&#8220;HPLC&#8221;), ultra performance liquid chromatography (&#8220;UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221; and together with HPLC, referred to as &#8220;LC&#8221;) and mass spectrometry (&#8220;MS&#8221;) </font><font style="font-family:Times New Roman;font-size:10pt;">technology</font><font style="font-family:Times New Roman;font-size:10pt;"> systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed together (&#8220;LC-MS&#8221;) and sold as </font><font style="font-family:Times New Roman;font-size:10pt;">integrated </font><font style="font-family:Times New Roman;font-size:10pt;">instrument systems using a common software platform and are</font><font style="font-family:Times New Roman;font-size:10pt;"> used along with other analytical instruments. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as &#8220;proteomics&#8221;), food safety analysis and environmental testing. LC-MS instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine</font><font style="font-family:Times New Roman;font-size:10pt;"> a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (&#8220;TA</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments, which are used in predicting the suitability of fine chemicals, polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments and are typically purchased by customers as part of the instrument system.</font></p>
CY2009 us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
-5162000 USD
CY2009 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-90280000 USD
CY2009 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3634000 USD
CY2009 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-87411000 USD
CY2011 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
50313000 USD
CY2011 us-gaap Interest Paid Net
InterestPaidNet
19658000 USD
CY2010 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
39688000 USD
CY2010 us-gaap Interest Paid Net
InterestPaidNet
10564000 USD
CY2009 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
23818000 USD
CY2009 us-gaap Interest Paid Net
InterestPaidNet
13020000 USD
CY2008Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
428522000 USD
CY2011 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5824000 USD
CY2010 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-15037000 USD
CY2009 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
36276000 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
661005000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
848949000 USD
CY2008Q4 us-gaap Shares Issued
SharesIssued
148069000 shares
CY2011Q4 us-gaap Shares Issued
SharesIssued
152757000 shares
CY2009Q4 us-gaap Shares Issued
SharesIssued
148831000 shares
CY2010Q4 us-gaap Shares Issued
SharesIssued
151054000 shares
CY2011 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
58000 shares
CY2011 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
264000 shares
CY2010 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
62000 shares
CY2010 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
228000 shares
CY2010 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1933000 shares
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1381000 shares
CY2009 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
88000 shares
CY2009 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
514000 shares
CY2009 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
160000 shares
CY2009 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3244000 USD
CY2010 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24480000 USD
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
27340000 USD
CY2009 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
211377000 USD
CY2010 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
296292000 USD
CY2011 wat Consolidated Entities
ConsolidatedEntities
The Company consolidates entities in which it owns or controls fifty percent or more of the voting shares.
CY2011 us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
Cash equivalents primarily represent highly liquid investments, with original maturities of 90&#160;days or less, primarily in bank deposits, U.S. treasury bills, U.S. treasury bill money market funds, Canadian U.S. dollar-denominated treasury bills, commercial paper and European government bond money market funds.
CY2011 us-gaap Accounts Receivable Additional Narrative Disclosure
AccountsReceivableAdditionalNarrativeDisclosure
Past due balances over 90&#160;days and over a specified amount are reviewed individually for collectibility.
CY2008Q4 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
7608000 USD
CY2011 wat Additions To Allowance For Doubtful Accounts And Sales Returns
AdditionsToAllowanceForDoubtfulAccountsAndSalesReturns
9932000 USD
CY2011 wat Deductions From Allowance For Doubtful Accounts And Sales Returns
DeductionsFromAllowanceForDoubtfulAccountsAndSalesReturns
-7544000 USD
CY2009Q4 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
6723000 USD
CY2010 wat Additions To Allowance For Doubtful Accounts And Sales Returns
AdditionsToAllowanceForDoubtfulAccountsAndSalesReturns
5508000 USD
CY2010 wat Deductions From Allowance For Doubtful Accounts And Sales Returns
DeductionsFromAllowanceForDoubtfulAccountsAndSalesReturns
-6035000 USD
CY2009 wat Additions To Allowance For Doubtful Accounts And Sales Returns
AdditionsToAllowanceForDoubtfulAccountsAndSalesReturns
6956000 USD
CY2009 wat Deductions From Allowance For Doubtful Accounts And Sales Returns
DeductionsFromAllowanceForDoubtfulAccountsAndSalesReturns
-7841000 USD
CY2011 us-gaap Property Plant And Equipment Income Statement Disclosures
PropertyPlantAndEquipmentIncomeStatementDisclosures
There were no material gains or losses from retirement or sale of assets in 2011, 2010 and 2009.
CY2010 us-gaap Property Plant And Equipment Income Statement Disclosures
PropertyPlantAndEquipmentIncomeStatementDisclosures
There were no material gains or losses from retirement or sale of assets in 2011, 2010 and 2009.
CY2009 us-gaap Property Plant And Equipment Income Statement Disclosures
PropertyPlantAndEquipmentIncomeStatementDisclosures
There were no material gains or losses from retirement or sale of assets in 2011, 2010 and 2009.
CY2010Q4 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
626000 USD
CY2010Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
626000 USD
CY2011Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
142966000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
897361000 USD
CY2011Q4 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
81000 USD
CY2011Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1061075000 USD
CY2011Q4 wat Waters Restoration Plan Assets
WatersRestorationPlanAssets
20667000 USD
CY2011Q4 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
1317000 USD
CY2011Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1317000 USD
CY2010Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
87975000 USD
CY2010Q4 us-gaap Short Term Investments
ShortTermInvestments
637921000 USD
CY2010Q4 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
424000 USD
CY2010Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
746308000 USD
CY2010Q4 wat Waters Restoration Plan Assets
WatersRestorationPlanAssets
19988000 USD
CY2009 wat Additional Interest Expense Recorded From Interest Rate Swap Agreements
AdditionalInterestExpenseRecordedFromInterestRateSwapAgreements
2000000 USD
CY2011 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
-2233000 USD
CY2011 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
-1035000 USD
CY2011Q4 us-gaap Maturity Of Foreign Currency Derivatives
MaturityOfForeignCurrencyDerivatives
The periods of these forward contracts typically range from one to three months and have varying notional amounts, which are intended to be consistent with changes in the underlying exposures.
CY2010Q4 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
136000000 USD
CY2011Q4 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
161000000 USD
CY2009Q4 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
138000000 USD
CY2007Q3 wat Contract Notional Amount Of Interest Rate Swap Agreements
ContractNotionalAmountOfInterestRateSwapAgreements
50000000 USD
CY2009 us-gaap Unrealized Gain Loss On Interest Rate Cash Flow Hedges Pretax Accumulated Other Comprehensive Income Loss
UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
2000000 USD
CY2010 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
-39000 USD
CY2009 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
1448000 USD
CY2010 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
-8138000 USD
CY2009 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
5162000 USD
CY2011 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
-3268000 USD
CY2010 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
-8177000 USD
CY2009 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
6610000 USD
CY2007Q3 us-gaap Number Of Interest Rate Derivatives Held
NumberOfInterestRateDerivativesHeld
2 pure
CY2010Q4 us-gaap Interest Rate Cash Flow Hedge Liability At Fair Value
InterestRateCashFlowHedgeLiabilityAtFairValue
0 USD
CY2011Q4 us-gaap Interest Rate Cash Flow Hedge Liability At Fair Value
InterestRateCashFlowHedgeLiabilityAtFairValue
0 USD
CY2009Q4 us-gaap Interest Rate Cash Flow Hedge Liability At Fair Value
InterestRateCashFlowHedgeLiabilityAtFairValue
0 USD
CY2011Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
120.00
CY2011Q4 wat Preferred Share Purchase Rights Triggering Event
PreferredSharePurchaseRightsTriggeringEvent
When a person or group actually has acquired 15% or more of Waters&#8217; common stock, the Rights will then become exercisable for a number of shares of Waters&#8217; common stock with a market value of twice the $120.00 exercise price of each Right.
CY2011Q4 wat Preferred Share Purchase Rights Redemption Provision
PreferredSharePurchaseRightsRedemptionProvision
The Board of Directors may redeem the Rights at a price of $0.001&#160;per Right up until 10&#160;days following a public announcement that any person or group has acquired 15% or more of the Company&#8217;s common stock.
CY2011Q4 wat Preferred Share Purchase Rights Number Of Securities Called
PreferredSharePurchaseRightsNumberOfSecuritiesCalled
When they first become exercisable, each Right will entitle its holder to buy from Waters one one-hundredth of a share of new Series&#160;A Junior Participating Preferred Stock (authorized limit of 4,000) for $120.00.
CY2010 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
27000000 USD
CY2011 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
10175000 USD
CY2011 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-8189000 USD
CY2010 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
7618000 USD
CY2010 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-6455000 USD
CY2009Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10109000 USD
CY2008Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10276000 USD
CY2009 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5725000 USD
CY2009 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-5892000 USD
CY2011 us-gaap Advertising Expense
AdvertisingExpense
11000000 USD
CY2010 us-gaap Advertising Expense
AdvertisingExpense
10000000 USD
CY2009 us-gaap Advertising Expense
AdvertisingExpense
10000000 USD
CY2011Q4 wat Intangible Assets Gross
IntangibleAssetsGross
431675000 USD
CY2011Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
71993000 USD
CY2011Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12293000 USD
CY2011Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
128578000 USD
CY2010Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
63475000 USD
CY2010Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
17301000 USD
CY2010Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
123524000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
280986000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
518081000 USD
CY2010Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
466425000 USD
CY2010Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
251365000 USD
CY2011 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
6000000 USD
CY2010 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
9000000 USD
CY2009 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
7000000 USD
CY2011Q4 wat Capitalized Costs For Sofware Developed For Internal Use Net
CapitalizedCostsForSofwareDevelopedForInternalUseNet
3000000 USD
CY2010Q4 wat Capitalized Costs For Sofware Developed For Internal Use Net
CapitalizedCostsForSofwareDevelopedForInternalUseNet
4000000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
239683000 USD
CY2011 us-gaap Finite Lived Intangible Assets Average Useful Life
FiniteLivedIntangibleAssetsAverageUsefulLife
7 pure
CY2010Q4 wat Intangible Assets Gross
IntangibleAssetsGross
403381000 USD
CY2010Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
222065000 USD
CY2010 us-gaap Finite Lived Intangible Assets Average Useful Life
FiniteLivedIntangibleAssetsAverageUsefulLife
7 pure
CY2011 wat Intangible Assets Gross Foreign Currency Translation Adjustments
IntangibleAssetsGrossForeignCurrencyTranslationAdjustments
-6000000 USD
CY2011 wat Intangible Assets Accumulated Amortization Foreign Currency Translation Adjustments
IntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationAdjustments
-5000000 USD
CY2011 us-gaap Future Amortization Expense Year One
FutureAmortizationExpenseYearOne
32000000 USD
CY2011Q2 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2501000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
115895000 USD
CY2011 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-102528000 USD
CY2010 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-97312000 USD
CY2009 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-73351000 USD
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-3105000 USD
CY2011Q2 us-gaap Interest Expense
InterestExpense
4083000 USD
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
713000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
112525000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18036000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
94489000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.03
CY2011 us-gaap Future Amortization Expense Year Three
FutureAmortizationExpenseYearThree
45000000 USD
CY2011 us-gaap Future Amortization Expense Year Four
FutureAmortizationExpenseYearFour
45000000 USD
CY2011 us-gaap Future Amortization Expense Year Five
FutureAmortizationExpenseYearFive
45000000 USD
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
4000000 USD
CY2010Q4 us-gaap Long Term Investments
LongTermInvestments
4000000 USD
CY2011 us-gaap Future Amortization Expense Year Two
FutureAmortizationExpenseYearTwo
45000000 USD
CY2011Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
115000000 USD
CY2010Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
103000000 USD
CY2011 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-1000000 USD
CY2011 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
29000000 USD
CY2010 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
29000000 USD
CY2011Q4 wat Debt
Debt
990832000 USD
CY2010Q4 wat Debt
Debt
766055000 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
82108000 USD
CY2010 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
71137000 USD
CY2009 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
59472000 USD
CY2011 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
33242000 USD
CY2010 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
21599000 USD
CY2009 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
24080000 USD
CY2011 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
5661000 USD
CY2010 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
3491000 USD
CY2009 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
3757000 USD
CY2011 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
37381000 USD
CY2010 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
31010000 USD
CY2009 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
35502000 USD
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
178238000 USD
CY2010 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
153252000 USD
CY2009 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
135328000 USD
CY2011 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3679000 USD
CY2010 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2269000 USD
CY2009 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2442000 USD
CY2009 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1080000 USD
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5824000 USD
CY2010 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15037000 USD
CY2009 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3867000 USD
CY2010 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-2109000 USD
CY2011Q4 wat Net Operating Loss Carryforwards And Credits Deferred Tax Assets
NetOperatingLossCarryforwardsAndCreditsDeferredTaxAssets
18242000 USD
CY2010Q4 wat Net Operating Loss Carryforwards And Credits Deferred Tax Assets
NetOperatingLossCarryforwardsAndCreditsDeferredTaxAssets
21359000 USD
CY2011Q4 wat Depreciation Deferred Tax Assets
DepreciationDeferredTaxAssets
12990000 USD
CY2010Q4 wat Depreciation Deferred Tax Assets
DepreciationDeferredTaxAssets
10339000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
22616000 USD
CY2010Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
24477000 USD
CY2011Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
4941000 USD
CY2010Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
5896000 USD
CY2011Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
3226000 USD
CY2010Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
3093000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
30371000 USD
CY2010Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
23976000 USD
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
11349000 USD
CY2010Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8711000 USD
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
131177000 USD
CY2010Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
119288000 USD
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10248000 USD
CY2010Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10361000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
120929000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
108927000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
13263000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
10877000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
9818000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
10308000 USD
CY2011Q4 wat Indefinite Lived Intangibles Deferred Tax Liabilities
IndefiniteLivedIntangiblesDeferredTaxLiabilities
17665000 USD
CY2010Q4 wat Indefinite Lived Intangibles Deferred Tax Liabilities
IndefiniteLivedIntangiblesDeferredTaxLiabilities
19901000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
171000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
119000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
40917000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
41205000 USD
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
80012000 USD
CY2011Q4 wat Future Minimum Rents Payable In Five Years And Thereafter
FutureMinimumRentsPayableInFiveYearsAndThereafter
12392000 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
28000000 USD
CY2011Q4 wat Domestic Federal And State Net Operating Loss Carryforward Deferred Tax Assets
DomesticFederalAndStateNetOperatingLossCarryforwardDeferredTaxAssets
less than $1 million
CY2010Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
67722000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
27442000 USD
CY2010Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
21437000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
56000000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
48000000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
24000000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
20000000 USD
CY2009Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
71000000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
14000000 USD
CY2011Q4 wat Foreign Net Operating Loss Deferred Tax Assets Pre Tax
ForeignNetOperatingLossDeferredTaxAssetsPreTax
2000000 USD
CY2009Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84000000 USD
CY2011Q4 wat Foreign Net Operating Loss Deferred Tax Assets Less Than One Million
ForeignNetOperatingLossDeferredTaxAssetsLessThanOneMillion
less than $1 million
CY2011 wat Unremitted Earnings Of Foreign Subsidiaries
UnremittedEarningsOfForeignSubsidiaries
2000000000 USD
CY2008Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
77295000 USD
CY2009Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
77924000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
71523000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
73199000 USD
CY2011 wat Increase In Other Uncertain Tax Benefits
IncreaseInOtherUncertainTaxBenefits
1676000 USD
CY2010 wat Increase In Other Uncertain Tax Benefits
IncreaseInOtherUncertainTaxBenefits
5095000 USD
CY2009 wat Increase In Other Uncertain Tax Benefits
IncreaseInOtherUncertainTaxBenefits
5184000 USD
CY2011 wat Expected Reduction In Unrecognized Tax Benefits In Next Twelve Months Resulting From Lapse Of Applicable Statute Of Limitations
ExpectedReductionInUnrecognizedTaxBenefitsInNextTwelveMonthsResultingFromLapseOfApplicableStatuteOfLimitations
4000000 USD
CY2010 wat Percentage Point Change In Effective Tax Rate
PercentagePointChangeInEffectiveTaxRate
-2.1 pure
CY2011Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
23829000 USD
CY2011Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
18407000 USD
CY2011Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
13332000 USD
CY2011Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
7036000 USD
CY2009 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
34000000 USD
CY2011 wat License Fees Paid Less Than One Million
LicenseFeesPaidLessThanOneMillion
less than $1 million
CY2010 wat License Fees Paid Less Than One Million
LicenseFeesPaidLessThanOneMillion
less than $1 million
CY2009 wat License Fees Paid Less Than One Million
LicenseFeesPaidLessThanOneMillion
less than $1 million
CY2011 wat Purchase Price Calculation For Shares Of Stock Under Employee Stock Purchase Plan
PurchasePriceCalculationForSharesOfStockUnderEmployeeStockPurchasePlan
The purchase price for each share of stock is the lesser of 90% of the market price on the first day of the plan period or 100% of the market price on the last day of the plan period.
CY2011Q4 wat Maximum Contribution Allowed Under Employee Stock Purchase Plan As Of Employees Earnings
MaximumContributionAllowedUnderEmployeeStockPurchasePlanAsOfEmployeesEarnings
0.15 pure
CY2009 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
1000000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
67000000 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
45000000 USD
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13000000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
92000000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
4.3 pure
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
91000000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
56.56
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
5.9 pure
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1400000 shares
CY2011Q4 wat Total Number Of Shares Purchased Under Employee Stock Purchase Plan
TotalNumberOfSharesPurchasedUnderEmployeeStockPurchasePlan
1100000 shares
CY2010Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
3700000 shares
CY2009Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
5100000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4800000 shares
CY2010 wat Compensation Expense Related To Employee Stock Purchase Plan Less Than One Million
CompensationExpenseRelatedToEmployeeStockPurchasePlanLessThanOneMillion
less than $1 million
CY2011 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
1000000 USD
CY2011 wat Plan Period Employee Stock Purchase Plan In Months
PlanPeriodEmployeeStockPurchasePlanInMonths
3 pure
CY2010Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
43.45
CY2009Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
45.17
CY2010 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24852000 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27579000 USD
CY2009 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28255000 USD
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.305 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011 pure
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029 pure
CY2011 wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
79.10
CY2010 wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
78.21
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
29.67
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
23.97
CY2009 wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
58.46
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.65
CY2011Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments In Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsInYearTwo
6100000 USD
CY2011Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments In Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsInYearThree
7680000 USD
CY2011Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments In Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsInYearFour
8387000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
658000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
667000 shares
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 pure
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
608000 shares
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 pure
CY2009 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.376 pure
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.271 pure
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5560000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-28000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4809000 shares
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
50.19
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
80.87
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.71
CY2011Q4 wat Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
21.39
CY2011Q4 wat Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
79.15
CY2010Q4 wat Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
21.39
CY2010Q4 wat Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
80.97
CY2011 wat Weighted Average Exercise Price Of Options Exercised
WeightedAverageExercisePriceOfOptionsExercised
40.64
CY2011 wat Exercise Price Range Of Options Exercised Lower Range Limit
ExercisePriceRangeOfOptionsExercisedLowerRangeLimit
21.39
CY2011Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments In Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsInYearFive
9454000 USD
CY2011 wat Exercise Price Range Of Options Exercised Upper Range Limit
ExercisePriceRangeOfOptionsExercisedUpperRangeLimit
77.94
CY2011 wat Exercise Price Range Of Options Canceled Lower Range Limit
ExercisePriceRangeOfOptionsCanceledLowerRangeLimit
36.25
CY2011 wat Exercise Price Range Of Options Canceled Upper Range Limit
ExercisePriceRangeOfOptionsCanceledUpperRangeLimit
80.97
CY2011 wat Exercise Price Range Of Options Granted Lower Range Limit
ExercisePriceRangeOfOptionsGrantedLowerRangeLimit
78.10
CY2011 wat Exercise Price Range Of Options Granted Upper Range Limit
ExercisePriceRangeOfOptionsGrantedUpperRangeLimit
79.15
CY2011Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4809000 shares
CY2011Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
56.71
CY2011Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1
6.0 pure
CY2011Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2917000 shares
CY2011Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
47.95
CY2011 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1492000 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000 shares
CY2010 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2500000 shares
CY2009 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3300000 shares
CY2010 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1672000 shares
CY2009 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1065000 shares
CY2011Q3 us-gaap Gross Profit
GrossProfit
271524000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
125439000 USD
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-12644000 USD
CY2011 wat Other Comprehensive Income Net Foreign Currency Adjustments
OtherComprehensiveIncomeNetForeignCurrencyAdjustments
-12644000 USD
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
966000 USD
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
339000 USD
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
627000 USD
CY2011 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
-12243000 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-24260000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
408708000 USD
CY2010 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-24568000 USD
CY2010 wat Other Comprehensive Income Net Foreign Currency Adjustments
OtherComprehensiveIncomeNetForeignCurrencyAdjustments
-24568000 USD
CY2010 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
19000 USD
CY2010 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
7000 USD
CY2010 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
CY2010 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
-2813000 USD
CY2010 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-27369000 USD
CY2010 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
354394000 USD
CY2009 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
19405000 USD
CY2009 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
2766000 USD
CY2009 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
968000 USD
CY2009 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1798000 USD
CY2009 wat Other Comprehensive Income Net Foreign Currency Adjustments
OtherComprehensiveIncomeNetForeignCurrencyAdjustments
21203000 USD
CY2009 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-38000 USD
CY2009 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-13000 USD
CY2009 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-25000 USD
CY2009 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
2977000 USD
CY2009 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
24155000 USD
CY2009 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
347468000 USD
CY2011 us-gaap Defined Benefit Plan Alternative Method Used To Amortize Net Gains And Losses
DefinedBenefitPlanAlternativeMethodUsedToAmortizeNetGainsAndLosses
amortize cumulative actuarial gains and losses in excess of 10% of the larger of the market-related value of plan assets and the projected benefit obligation over the expected future service of active participants.
CY2011Q4 wat Estimated Future Employer Contributions To Defined Benefit Plans In Next Fiscal Year Range Minimum
EstimatedFutureEmployerContributionsToDefinedBenefitPlansInNextFiscalYearRangeMinimum
7000000 USD
CY2011Q4 wat Estimated Future Employer Contributions To Defined Benefit Plans In Next Fiscal Year Range Maximum
EstimatedFutureEmployerContributionsToDefinedBenefitPlansInNextFiscalYearRangeMaximum
9000000 USD
CY2011Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
108727000 USD
CY2010Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
108929000 USD
CY2011Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments In Year One
DefinedBenefitPlanExpectedFutureBenefitPaymentsInYearOne
5283000 USD
CY2011Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments In Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsInFiveFiscalYearsThereafter
62540000 USD
CY2011 wat Percent Of Net Sales Derived From Operations Outside United States
PercentOfNetSalesDerivedFromOperationsOutsideUnitedStates
0.71 pure
CY2010 wat Percent Of Net Sales Derived From Operations Outside United States
PercentOfNetSalesDerivedFromOperationsOutsideUnitedStates
0.70 pure
CY2009 wat Percent Of Net Sales Derived From Operations Outside United States
PercentOfNetSalesDerivedFromOperationsOutsideUnitedStates
0.69 pure
CY2011Q2 us-gaap Sales Revenue Net
SalesRevenueNet
427603000 USD
CY2011Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
169829000 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
257774000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117124000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22254000 USD
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91649000 shares
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.01
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93313000 shares
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
447627000 USD
CY2011Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
176103000 USD
CY2010Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20076000 USD
CY2010Q2 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2642000 USD
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21534000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
137147000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.54
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89324000 shares
CY2010Q2 us-gaap Sales Revenue Net
SalesRevenueNet
367700000 USD
CY2010Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
145932000 USD
CY2010Q2 us-gaap Gross Profit
GrossProfit
221768000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.51
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90566000 shares
CY2010Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106693000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23014000 USD
CY2011Q3 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2504000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
120567000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
5052000 USD
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
813000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
116328000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16253000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
100075000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.09
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91662000 shares
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.07
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93271000 shares
CY2011Q4 us-gaap Sales Revenue Net
SalesRevenueNet
454534000 USD
CY2011Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
180318000 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
274216000 USD
CY2011Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
121211000 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23372000 USD
CY2011Q4 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2369000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
127264000 USD
CY2011Q4 us-gaap Interest Expense
InterestExpense
6159000 USD
CY2011Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
613000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
121718000 USD
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20461000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
101257000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.12
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90688000 shares
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.10
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92060000 shares
CY2011Q4 us-gaap Sales Revenue Net
SalesRevenueNet
521420000 USD
CY2011Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
204243000 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
317177000 USD
CY2011Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126237000 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23707000 USD
CY2011Q4 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2359000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
164874000 USD
CY2011Q4 us-gaap Interest Expense
InterestExpense
6677000 USD
CY2011Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
484000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
158681000 USD
CY2010Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
92357000 USD
CY2010Q2 us-gaap Interest Expense
InterestExpense
2614000 USD
CY2010Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
329000 USD
CY2010Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
90072000 USD
CY2010Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14554000 USD
CY2010Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
75518000 USD
CY2010Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106939000 USD
CY2010Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20807000 USD
CY2010Q3 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2592000 USD
CY2010Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
105584000 USD
CY2010Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.38
CY2010Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91583000 shares
CY2010Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.36
CY2010Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93344000 shares
CY2010Q3 us-gaap Interest Expense
InterestExpense
3621000 USD
CY2010Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
448000 USD
CY2010Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
102411000 USD
CY2010Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17489000 USD
CY2010Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
84922000 USD
CY2010Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.92
CY2010Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92612000 shares
CY2010Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
148176000 USD
CY2010Q4 us-gaap Interest Expense
InterestExpense
3879000 USD
CY2010Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
562000 USD
CY2010Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.81
CY2010Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93629000 shares
CY2010Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.79
CY2010Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95223000 shares
CY2010Q3 us-gaap Sales Revenue Net
SalesRevenueNet
391055000 USD
CY2010Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
155133000 USD
CY2010Q3 us-gaap Gross Profit
GrossProfit
235922000 USD
CY2010Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.90
CY2010Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94278000 shares
CY2010Q4 us-gaap Sales Revenue Net
SalesRevenueNet
401038000 USD
CY2010Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
162985000 USD
CY2010Q4 us-gaap Gross Profit
GrossProfit
238053000 USD
CY2010Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111306000 USD
CY2010Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20524000 USD
CY2010Q4 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2408000 USD
CY2010Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
103815000 USD
CY2010Q4 us-gaap Interest Expense
InterestExpense
3810000 USD
CY2010Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
516000 USD
CY2010Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
100521000 USD
CY2010Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5802000 USD
CY2010Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
94719000 USD
CY2010Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.03
CY2010Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91714000 shares
CY2010Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.02
CY2010Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93286000 shares
CY2010Q4 us-gaap Sales Revenue Net
SalesRevenueNet
483578000 USD
CY2010Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
189253000 USD
CY2010Q4 us-gaap Gross Profit
GrossProfit
294325000 USD
CY2010Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120518000 USD
CY2010Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22867000 USD
CY2010Q4 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2764000 USD
CY2010Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
144859000 USD
CY2010Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18255000 USD
CY2010Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
126604000 USD

Files In Submission

Name View Source Status
0001193125-12-077126-index-headers.html Edgar Link pending
0001193125-12-077126-index.html Edgar Link pending
0001193125-12-077126.txt Edgar Link pending
0001193125-12-077126-xbrl.zip Edgar Link pending
d274872d10k.htm Edgar Link pending
d274872dex211.htm Edgar Link pending
d274872dex231.htm Edgar Link pending
d274872dex311.htm Edgar Link pending
d274872dex312.htm Edgar Link pending
d274872dex321.htm Edgar Link pending
d274872dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g274872g52u89.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wat-20111231.xml Edgar Link completed
wat-20111231.xsd Edgar Link pending
wat-20111231_cal.xml Edgar Link unprocessable
wat-20111231_def.xml Edgar Link unprocessable
wat-20111231_lab.xml Edgar Link unprocessable
wat-20111231_pre.xml Edgar Link unprocessable